Can This Biotech Improve On Bristol-Myers' Blockbuster Cancer Drug?Investors Business Daily • 11/11/19
Should Merck Investors Worry About Bristol Myers' Lung Cancer Drug Results?The Motley Fool • 11/04/19
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 10/31/19
Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish LineThe Motley Fool • 10/31/19
All You Need to Know About Bristol-Myers (BMY) Rating Upgrade to BuyZacks Investment Research • 10/31/19
Bristol-Myers Squibb (BMY) Q3 Earnings and Revenues Top EstimatesZacks Investment Research • 10/31/19
Bristol-Myers Squibb (BMY) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/24/19